Treatment of rare bleeding disorders
https://doi.org/10.21682/2311-1267-2020-7-4-71-76
Abstract
Rare bleeding disorders include inherited deficiencies of fibrinogen, factors (F)II, FV, FVII, FX, FXI, FXII, and FV + FVIII, as well as a multiple deficiency of vitamin K-dependent coagulation factors. Some of these deficiencies are more studied, due to the large number of patients, some are extremely rare, and so at this stage it is quite difficult for them to develop a universal approach to therapy and prophylactic treatment. The purpose of this review was to evaluate treatment options for these deficiencies.
About the Authors
D. B. Florinskiy
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Russian Federation
Resident in Pediatrics Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia.
1 Samory Mashela St., Moscow, 117997.
P. A. Zharkov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
Russian Federation
Russian Federation
Dr. of Sci. (Med.), Hematologist Advisory Unit, Short-Term Hospital Pediatrician, Head of the Hemostasis Research Group of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology, Ministry of Health of Russia.
1 Samory Mashela St., Moscow, 117997.
References
1. Mannucci P.M., Duga S., Peyvandi F. Recessively inherited coagulation disorders. Blood 2004;104:1243-52. PMID: 15138162.
2. Mumford A.D., Ackroyd S., Alikhan R., Bowles L., Chowdary P., Grainger J., Mainwaring J., Mathias M., O’Connell N. BCSH Committee Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014;167:304-26. PMID: 25100430.
3. Caudill J.S., Nichols W.L., Plumhoff E.A., Schulte S.L., Winters J.L., Gastineau D.A., Rodriguez V. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion 2009;49(4):765-70. PMID: 19192257.
4. Zozulya N.I., Svirin P.V. Diagnosis and treatment rare bleeding disorders: Factor II, VII, X deficiency. National clinical guidelines, 2014. (In Russ.).
5. Tabibian S., Yavar S., Shams M., Safa M., Gholami M.S., Heydari F., Ahmadi A., Rashidpanah J., Dorgalaleh A. A comprehensive overview of coagulation factor V and congenital factor V deficiency. Semin Thromb Hemost 2019;45(5):523-43. PMID: 31121608.
6. Stirling Y., Woolf L., North W.R., Seghatchian M.J., Meade T.W. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176-82. PMID: 6084322.
7. Mariani G., Bernardi F. Factor VII deficiency. Semin Thromb Hemost 2009;35(4):400-6. PMID: 20391303.
8. Woehrle D., Martinez M., Bolliger D. Hereditary heterozygous factor VII deficiency in patients undergoing surgery: clinical relevance. Anaesthesist 2016;65(10):746-54. PMID: 27586406.
9. Vorstand der Bundesarztekammer auf Empfehlung des Wissenschaftlichen Beirats. Querschnittsleitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten, 2014; 4. uberarbeitete und aktualisierte Auflage.
10. van Geffen M., Mathijssen N.C.J., Holme P.A., Britta A.P., van Gorkom L., van Kraaij M.G.J., Masereeuw R., Peyvandi F., van Heerde W.L. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. Thromb Res 2013;132(2):256-62. PMID: 23834817.
11. State Register of Medicines. Access mode: [Electronic resource]. URL: http://grls.rosminzdrav.ru/Default.aspx. (In Russ.).
12. Livnat T., Tamarin I., Mor Y., Winckler H., Horowitz Z., Korianski Y., Bar-Zakay B., Seligsohn U., Salomon O. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Thromb Haemost 2009;102:487-92. PMID: 19718468.
13. Dorgalaleh A., Rashidpanah J. Blood coagulation factor XIII and factor XIII deficiency. Blood Rev 2016;30(6):461-75. PMID: 27344554.
14. Lusher J., Pipe S.W., Alexander S., Nugent D. Prophylactic therapy with Fibrogammin® P is associated with a decreased incidence of bleeding episodes: a retrospective study. Haemophilia 2010;16:316-21. PMID: 20017752.
15. Karaman S., Akkaya E., Genc S., Bilgili F., Kendirci A.S., Tugcu D., Unuvar A., Karakas Z., Demirkol D., Bayramoglu Z., Omer B. Congenital Factor XIII Deficiency With the Presence of Inhibitor: A Case Study. J Pediatr Hematol Oncol 2019. doi: 10.1097/MPH.0000000000001671.
16. Key N.S., Negrier C. Coagulation factor concentrates: past, present, and future. Lancet 2007;370(9585):439-48. PMID: 17679021.
17. Spreafico M., Peyvandi F. Combined Factor V and Factor VIII Deficiency. Semin Thromb Hemost 2009;35(4):390-9. PMID: 19598067.
18. Brenner B., Kuperman A.A., Watzka M., Oldenburg J. Vitamin K-dependent coagulation factors deficiency. Semin Thromb Hemost 2009 Jun;35(4):439-46. PMID: 19598072.
19. McMahon M.J., James A.H. Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol 2001;97:808-9. PMID: 11336760.
20. Peyvandi F., Palla R., Menegatti M., Siboni S.M., Halimeh S., Faeser B., Pergantou H., Platokouki H., Giangrande P., Peerlinck K., Celkan T., Ozdemir N., Bidlingmaier C., Ingerslev J., Giansily-Blaizot M., Schved J.F., Gilmore R., Gadisseur A., Benedik-Dolnicar M., Kitanovski L., Mikovic D., Musallam K.M., Rosendaal F.R.; European Network of Rare Bleeding Disorders Group. Coagulation Factor Activity and Clinical Bleeding Severity in Rare Bleeding Disorders: Results From the European Network of Rare Bleeding Disorders J Thromb Haemost 2012;10(4):615-21. PMID: 22321862.
Review
For citations:
Florinskiy D.B., Zharkov P.A. Treatment of rare bleeding disorders. Russian Journal of Pediatric Hematology and Oncology. 2020;7(4):71-76. (In Russ.) https://doi.org/10.21682/2311-1267-2020-7-4-71-76
Views:
898
Email this article 